Advertisement
Screener

OCUGEN, INC. (OCGN) Other

OCUGEN, INC. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-03-04: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock · OCGN · NASDAQ.
  • 2025-03-05: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock · OCGN · NASDAQ.
  • 2024-04-29: Form 10-K/A; Item Stock registered under Section 12(b); As filed Common Stock · OCGN · NASDAQ.
  • 2024-04-16: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock · OCGN · NASDAQ.
FiledFormItemAs filed
2026-03-0410-KStock registered under Section 12(b)Common Stock · OCGN · NASDAQ
2025-03-0510-KStock registered under Section 12(b)Common Stock · OCGN · NASDAQ
2024-04-2910-K/AStock registered under Section 12(b)Common Stock · OCGN · NASDAQ
2024-04-1610-KStock registered under Section 12(b)Common Stock · OCGN · NASDAQ
2023-02-2810-KStock registered under Section 12(b)Common Stock · OCGN · NASDAQ
2022-05-0610-QSmaller reporting companyNo
2022-02-2810-KStock registered under Section 12(b)Common Stock · OCGN · NASDAQ
2022-02-2810-KSmaller reporting companyNo
2022-02-2810-KWell-known seasoned issuerYes
2021-03-1910-KStock registered under Section 12(b)Common Stock · OCGN · NASDAQ
2021-03-1910-KWell-known seasoned issuerYes
2020-03-2710-KStock registered under Section 12(b)Common Stock · OCGN · NASDAQ
2019-11-1210-QEmerging growth companyYes
2019-08-0910-QStock registered under Section 12(b)Common Stock · HSGX · NASDAQ
2019-08-0910-QEmerging growth companyYes
2019-05-1510-QEmerging growth companyYes
2019-03-2210-KEmerging growth companyYes
2018-11-0810-QEmerging growth companyYes

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02
SAB Biotherapeutics, Inc. (SABS)United States$0.306B-25.49
AGENUS INC (AGEN)United States$0.383B1.41
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
Surrozen, Inc./DE (SRZN)United States$0.395B